Cynosure, a provider of laser systems for the removal of hair, the treatment of vascular and pigmented lesions, and the temporary reduction of cellulite, priced its offering of 5 million shares at $15, a 15% premium to its $12-$14 range. Citigroup lead managed the deal. The stock is expected to commence trading on the Nasdaq under the ticker symbol "CYNO" on Friday.
